H. Lee Moffitt Cancer Center & Research Institute

Find an Investigator

Dana E. Rollison, PhD

Dana E. Rollison, PhD

Faculty Rank:

Associate Member

Titles:

  • Scientific Director, Cancer Registry

Department/Program Affiliations:

  • Risk Assessment,Detection & Intervention  
  • Cancer Registry  
  • Comprehensive Melanoma Research Center  

Primary Address:

H. Lee Moffitt Cancer Center &
Research Institute
12902 Magnolia Drive
Tampa, FL 33612

Office:

(813) 745-6530

USF Affiliations/College Department:

  • Medicine / Oncologic Sciences
  • Public Health / Epidemiology & Biostatistics

University Academic Rank:

Associate Professor

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Dana E. Rollison, PhD

Education & Training:

  • PhD, Johns Hopkins University, 2002 - Epidemiology
  • ScM, Johns Hopkins University, 1999 - Epidemiology
  • BS, University of Miami, 1997 - Biology

For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Dana E. Rollison, PhD

Research Interests:

Cancer epidemiology; infections and cancer; human polyomaviruses and cancer; cutaneous human papillomavirus infections and non-melanoma skin cancer; epidemiology of myelodysplastic syndromes



For corrections, please e-mail a request

Printer friendly version
Printer friendly version (including publications)

Dana E. Rollison, PhD

Publications:

  1. Agelli M, Clegg LX, Becker JC, Rollison DE. The etiology and epidemiology of merkel cell carcinoma. Curr Probl Cancer. 2010 Jan-Feb;34(1):14-37. Pubmedid: 20371072.   Pubmed ID: 20371072

  2. Hines LM, Risendal B, Slattery ML, Baumgartner KB, Giuliano AR, Sweeney C, Rollison DE, Byers T. Comparative analysis of breast cancer risk factors among Hispanic and non-Hispanic white women. Cancer. 2010 Jul;116(13):3215-3223. Pubmedid: 20564638. Pmcid: PMC2922031.   Pubmed ID: 20564638

  3. Iannacone MR, Michael KM, Giuliano AR, Waterboer T, Pawlita M, Rollison DE. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida. J Infect Dis. 2010 Mar;201(5):760-769. Pubmedid: 20105078.   Pubmed ID: 20105078

  4. Komrokji RS, Matacia-Murphy GM, Al Ali NH, Beg MS, Safa MM, Rollison DE, List AF. Outcome of patients with myelodysplastic syndromes in the Veterans Administration population. Leuk Res. 2010 Jan;34(1):59-62. Pubmedid: 19368972.   Pubmed ID: 19368972

  5. Rollison DE, Giuliano AR, Risendal BC, Sweeney C, Boulware D, Laronga C, Baumgartner KB, Byers T, Slattery ML. Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest. Breast Cancer Res Treat. 2010 Jun;121(3):661-669. Pubmedid: 19888649.   Pubmed ID: 19888649

  6. Rollison DE. JC Virus Infection A Cause of Colorectal Cancer?. J Clin Gastroenterol. 2010 Aug;44(7):466-468. Pubmedid: 20520564.   Pubmed ID: 20520564

  7. Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, Mackinnon J, Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control. 2009 Sep;20(7):1129-1138. Pubmedid: 19253025.   Pubmed ID: 19253025

  8. Patel NR, Rollison DE, Barnholtz-Sloan J, Mackinnon J, Green L, Giuliano AR. Racial and ethnic disparities in the incidence of invasive cervical cancer in Florida. Cancer. 2009 Sep;115(17):3991-4000. Pubmedid: 19544552.   Pubmed ID: 19544552

  9. Rollison DE, Helzlsouer KJ, Lee JH, Fulp W, Clipp S, Hoffman-Bolton JA, Giuliano AR, Platz EA, Viscidi RP. Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1515-1523. Pubmedid: 19383887. Pmcid: PMC2743003.   Pubmed ID: 19383887

  10. Zou JX, Rollison DE, Boulware D, Chen DT, Sloand EM, Pfannes LV, Goronzy JJ, Bai F, Painter JS, Wei S, Cosgrove D, List AF, Epling-Burnette PK. Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome. Leukemia. 2009 Jul;23(7):1288-1296. Pubmedid: 19282834.   Pubmed ID: 19282834

  11. Rollison D, Howlader N, Smith M, Strom S, Merritt W, Ries L, Edwards B, List A. Epidemiology of Myelodysplastic Syndromes and Chronic Myeloproliferative Disorders in the United States, 2001-2004: Utilizing Data from the NAACCR and SEER Programs. Blood. 2008 Jul;112(1):45-52. Pubmedid: 18443215.   Pubmed ID: 18443215

  12. Rollison D, Pawlita M, Giuliano A, Iannacone M, Sondak V, Messina J, Cruse C, Fenske N, Glass L, Kienstra M, Michael K, Waterboer T, Gheit T, Tommasino M. Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. Int J Cancer. 2008 Nov;123(10):2337-2342. Pubmedid: 18729188.   Pubmed ID: 18729188

  13. Rollison DE, Brownson RC, Hathcock HL, Newschaffer CJ. Case-control study of tobacco smoke exposure and breast cancer risk in Delaware. BMC Cancer. 2008 Jun;8:157-157. Pubmedid: 18518960.   Pubmed ID: 18518960

  14. Rollison DE, Giuliano AR, Sellers TA, Laronga C, Sweeney C, Risendal B, Baumgartner KB, Byers T, Slattery ML. Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol. 2008 Feb;167(4):447-456. Pubmedid: 18033764. Pmcid: PMC2925515.   Pubmed ID: 18033764

  15. Burnette PK, Bai F, Painter JS, Rollison DE, Salih HR, Krusch M, ZouJ, Ku E, Zhong B, Boulware D, Moscinski L, Wei S, Djeu JY, List AF. Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood. 2007 Jun;109(11):4816-4824. Pubmedid: 17341666.   Pubmed ID: 17341666

  16. Burnette PK, Painter J, Rollison D, Ku E, Vendron D, Widen R, Boulware D, Zou J, Bai F, List A. Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome. Leukemia. 2007 Apr;21(4):659-67. Pubmedid: 17301813.   Pubmed ID: 17301813

  17. Rollison DE, Sexton WJ, Rodriguez AR, Kang LC, Daniel R, Shah KV. Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder. Int J Cancer. 2007 Mar;120(6):1248-1251. Pubmedid: 17192899.   Pubmed ID: 17192899

  18. Rollison D, Engels E, Halsey N, Shah K, Viscidi R, Helzlsouer K. Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):543-550. Pubmedid: 16537714.   Pubmed ID: 16537714

  19. Rollison D, Helzlsouer K, Pinney S. Personal hair dye use and cancer: a systematic literature review and evaluation of exposure assessment in studies published since 1992. J Toxicol Environ Health B Crit Rev. 2006 Sep;9(5):413-439. Pubmedid: 17492526.   Pubmed ID: 17492526

  20. Rollison D, Newschaffer C, Tao Y, Pollak M, Helzlsouer K. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer. Int J Cancer. 2006 Mar;118(5):1279-1284. Pubmedid: 16161053.   Pubmed ID: 16161053

  21. Rollison D. Epidemiologic studies of polyomaviruses and cancer: previous findings, methodologic challenges and future directions. Adv Exp Med Biol. 2006;577:342-356. Pubmedid: 16626047.   Pubmed ID: 16626047

  22. Engels E, Rollison D, Hartge P, Baris D, Cerhan J, Severson R, Cozen W, Davis S, Biggar R, Goedert J, Viscidi R. Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma. Int J Cancer. 2005 Dec;117(6):1013-1019. Pubmedid: 15986438.   Pubmed ID: 15986438

  23. Rollison D, Helzlsouer K, Halsey N, Shah K, Viscidi R. Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort. Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1448-1452. Pubmedid: 15941954.   Pubmed ID: 15941954

  24. Rollison D, Shah K, Major E. Response from authors: Re: Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int J Cancer. 2005;117(4):695-696. Pubmedid: 15912535.   Pubmed ID: 15912535

  25. Rollison D, Utaipat U, Ryschkewitsch C, Hou J, Goldthwaite P, Daniel R, Helzlsouer K, Burger P, Shah K, Major E. An investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int J Cancer. 2005 Feb;113(5):769-774. Pubmedid: 15499616.   Pubmed ID: 15499616

  26. Rollison D, Helzlsouer K. Processed meat consumption and adult gliomas in a Maryland cohort. Cancer Causes Control. 2004;15(1):99-100. Pubmedid: 15049327.   Pubmed ID: 15049327

  27. Rollison D, Page W, Crawford H, Gridley G, Wacholder S, Martin J, Engels E. Case-control study of cancer among US Army recruits exposed to simian virus 40-contaminated adenovirus vaccine. Am J Epidemiol. 2004;160(4):317-324. Pubmedid: 15286016.   Pubmed ID: 15286016

  28. Rollison D, Helzlsouer K, Alberg A, Hoffman S, Hou J, Daniel R, Shah K, Major E. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomarkers Prev. 2003;12(5):460-463. Pubmedid: 12750243.   Pubmed ID: 12750243

  29. Viscidi RP, Rollison DE, Viscidi E, Clayman B, Rubalcaba E, Daniel R, Major EO, Shah KV. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol. 2003 Mar;10(2):278-285. Pubmedid: 12626455.   Pubmed ID: 12626455

  30. Shah K, Rollison D. Investigation of the SV40--human cancer association: look for the full signature of the virus. Dis Markers. 2001;17(3):159-161. Pubmedid: 11790881.   Pubmed ID: 11790881

Dana E. Rollison, PhD

Below is a list of active grants where the faculty member is the Principal Investigator. Grants are sorted by sponsor and then sorted by start date, with the more recent grant shown first.

Pilot Case-Control Study of Telomere Length in Melanoma MCC# 15344

Sponsor: Moffitt Fdtn
Project Dates: January 1, 2009 to December 31, 2009
Earned to Date: $49,994

Epidemiologic Pilot Study of MDS Incidence in Florida (NO COST EXTENSION)

UF09024, Mod. #1
Sponsor: Univ of Florida
Project Dates: February 6, 2009 to December 31, 2010

Investigator  Contact Form


© Copyright 1996 - 2010 H. Lee Moffitt Cancer Center & Research Institute